Patent case: Rifaximin α, Germany
January 22, 2019
The provision of a crystal form of a polymorphic substance, which the skilled person inevitably obtains if he uses a process suggested by the state of the art for the production of the substance, represents the result of activities to be expected by a skilled person and does not therefore by itself involve an inventive step (Confirmation of Federal Court of Justice judgment of 24 July 2012 - XZR 126/09, GRUR 2012, 1130 - Leflunomid).
Case date:07 October 2018
Case number: X ZR 110/16
Court: Federal Court of Justice of Germany
A full summary of this case has been published on Kluwer IP Law.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
